• Info
  • Insider Trading

John W. Smither - Insider Trading & Ownership

Location
C/O Kythera Biopharmaceuticals, Inc., 27200 West Agoura Road, Suite 200, Calabasas, CA
Summary
The estimated net worth of John W. Smither is at least $985K dollars as of August 29, 2025. John W. Smither is the Chief Financial Officer of Arcutis Biotherapeutics, Inc. and owns shares of Arcutis Biotherapeutics, Inc. (ARQT) stock worth about $541K. John W. Smither is the Director of GENELUX Corp and owns shares of GENELUX Corp (GNLX) stock worth about $266K. John W. Smither is the Director of NewAmsterdam Pharma Co N.V. and owns shares of NewAmsterdam Pharma Co N.V. (NAMS) stock worth about $178K.
Signature
/s/ Thomas Zindrick, J.D. Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when John W. Smither files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of John W. Smither

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARQT Arcutis Biotherapeutics, Inc. Chief Financial Officer $541K Feb 13, 2024
GNLX GENELUX Corp Director $266K Aug 27, 2025
NAMS, NAMSW NewAmsterdam Pharma Co N.V. Director $178K Jan 6, 2025
AMTI Applied Molecular Transport Inc. Director Dec 27, 2023
EFTR eFFECTOR Therapeutics, Inc. Director Jun 22, 2023

Insider Transactions Reported by John W. Smither:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.